Selenia Full Field Digital Mammography System with software versions 5.0.x and 5.1.x The Selen...

FDA Device Recall #Z-2301-2013 — Class II — September 6, 2013

Recall Summary

Recall Number Z-2301-2013
Classification Class II — Moderate risk
Date Initiated September 6, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hologic, Inc.
Location Danbury, CT
Product Type Devices
Quantity 62 systems

Product Description

Selenia Full Field Digital Mammography System with software versions 5.0.x and 5.1.x The Selenia Full Field Digital Mammography system generates digital mammography images that can be used for screening and diagnosis of breast cancer. The Selenia Full Field Digital Mammography System is intended for use in the same clinical applications as traditional screen-film mammography systems. Mammography images can be interpreted on either hard copy film or soft copy review workstations, cleared for mammography

Reason for Recall

Software: When the Selenia upon meeting the hard drive threshold of 4,000 images, may delete the most recently dated images

Distribution Pattern

Worldwide Distribution - USA including the states of AL, AR, CA, CO, FL, IL, KY, LA, NE, NC, NJ, NY, OH, PA, TN, TX, UT, WA and WV., and the countries of Canada, Denmark, Iran, Italy, Mexico and Taiwan.

Lot / Code Information

Software versions 5.0.x and 5.1.x

Other Recalls from Hologic, Inc.

Recall # Classification Product Date
Z-1586-2026 Class II Brand Name: Aptima HPV Assay Product Name: Apt... Feb 18, 2026
Z-1095-2025 Class II The Rapid fFN Specimen Collection Tube (PN: 715... Jan 8, 2025
Z-0907-2025 Class II Panther Fusion GBS Assay REF PRD-04484 Kit cont... Dec 13, 2024
Z-0694-2025 Class II Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, RE... Nov 8, 2024
Z-0782-2024 Class II PANTHER FUSION System REF 9121010000 The P... Dec 15, 2023

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.